NEUROMETRIX, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-12-07: Form 8-K; Period of report 2012-12-07; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2012-10-25: Form 8-K; Period of report 2012-10-25; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2012-09-20: Form 8-K; Period of report 2012-09-19; Description 8.01 Other Events; Details 8.01.
- 2012-07-26: Form 8-K; Period of report 2012-07-26; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2012-12-07 | 8-K | 2012-12-07 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 The Company held a special meeting of stockholders (the “Special Meeting”) at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA 02111 on December 7, 2012. | v329959_8-k.htm |
| 2012-10-25 | 8-K | 2012-10-25 | 2.02 Results of Operations and Financial Condition | 2.02 On October 25, 2012, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and nine months ended September 30, 2012. | v326412_8k.htm |
| 2012-09-20 | 8-K | 2012-09-19 | 8.01 Other Events | 8.01 On September 20, 2012, NeuroMetrix, Inc. (“NeuroMetrix”) reported that it has received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that it has been granted a six month extension until March 18, 2013 of the grace period to regain compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on The NASDAQ Capital Market. | v324150_8-k.htm |
| 2012-07-26 | 8-K | 2012-07-26 | 2.02 Results of Operations and Financial Condition | 2.02 On July 26, 2012, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and six months ended June 30, 2012. | v319404_8k.htm |
| 2012-05-15 | 8-K | 2012-05-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 (b) Mr. Charles R. LaMantia’s term as a Class II Director of the Corporation concluded effective as of the NeuroMetrix, Inc. (the “Corporation”) Annual Meeting of Stockholders held on May 14, 2012 (the “Annual Meeting”). 5.07 The Corporation’s Annual Meeting was held at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA 02111. | v313300_8k.htm |
| 2012-04-24 | 8-K | 2012-04-24 | 2.02 Results of Operations and Financial Condition | 2.02 On April 24, 2012, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2012. | v310235_8k.htm |
| 2012-04-02 | 8-K | 2012-03-28 | 8.01 Other Events | 8.01 On March 28, 2012, NeuroMetrix, Inc. (NASDAQ: NURO) (the “Company”) accepted a purchase order from Wal-Mart Canada Corp. (“Wal-Mart Canada”), a subsidiary of Wal-Mart Stores, Inc. (NYSE: WMT), which operates approximately 100 pharmacies across Canada. | v308083_8-k.htm |
| 2012-03-23 | 8-K | 2012-03-22 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 (a) On March 22, 2012, NeuroMetrix, Inc. (the “Company”) received a notice from the Listing Qualifications Department of the NASDAQ Stock Market indicating that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued inclusion on The NASDAQ Capital Market under NASDAQ Listing Rule 5550(a)(2). | v307004_8-k.htm |
| 2012-03-13 | 8-K | 2012-03-12 | 8.01 Other Events | 8.01 On March 12, 2012, NeuroMetrix, Inc. (the “Company”) filed a prospectus supplement relating to the issuance (the “Issuance”) of 138,763 shares (the “Shares”) of its common stock, $0.0001 par value per share (the “Common Stock”). | v305648_8-k.htm |
| 2012-02-15 | 8-K | 2012-02-15 | 2.02 Results of Operations and Financial Condition | 2.02 On February 15, 2012, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2011. | v302781_8-k.htm |
| 2012-02-08 | 8-K | 2012-02-07 | 8.01 Other Events | 8.01 On February 7, 2012, NeuroMetrix, Inc. (“NeuroMetrix” or “we”) priced a public offering (the “Offering”) of up to 10,500,000 Units, with each Unit consisting of one share of common stock, par value $0.0001 per share, and a warrant to purchase one half of a share of common stock. | v301641_8k.htm |